About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.

Changing lives with every breath

At ResMed we believe that every breath is an opportunity to make a positive change to people’s lives. We’ve been helping to change lives since 1989 and now we’re unveiling a new brand that we believe embodies this philosophy. Have a look and see if you agree.

The ResMed story

When ResMed was formed in 1989, our primary purpose was to commercialize a device for treating obstructive sleep apnea (OSA), a major subset of sleep-disordered breathing (SDB).

Our Vision and Our Mission

Our Vision is to be the global solutions leader for SDB, COPD and other major chronic diseases. Our Mission is to improve the quality of life for patients, prevent progression of chronic diseases, and reduce overall healthcare system costs.

The executive team

ResMed’s executive team is committed to the highest standards of ethics and professional integrity, translating to great partnerships with our customers, our suppliers, and with our global ResMed team.

Read about some recent research in the industry.